OCT 19: India has made a major breakthrough in medical innovation with the development of its first indigenously discovered antibiotic, “Nafithromycin”, effective against resistant respiratory infections and especially beneficial for cancer patients and poorly controlled diabetics. Entirely conceptualized, developed, and clinically validated in India, this antibiotic marks a significant stride toward self-reliance in the pharmaceutical sector.
Developed by the Department of Biotechnology, Government of India, in collaboration with leading private pharma house Wockhardt, Nafithromycin exemplifies the power of industry-academia partnerships in driving innovation. Union Minister Dr. Jitendra Singh, while inaugurating the 3-day Medical Workshop on “Harnessing Artificial Intelligence for Multi-Omics Data Integration and Analysis”, stressed the importance of creating a self-sustainable innovation ecosystem with private sector participation and philanthropic support to achieve global recognition.
Citing another milestone, Dr. Singh highlighted India’s first indigenous clinical trial for Hemophilia gene therapy, conducted at Christian Medical College, Vellore, which achieved a 60–70% correction rate with zero bleeding episodes. Over 10,000 human genomes have already been sequenced in India, with plans to scale to one million, demonstrating the country’s growing leadership in genomic medicine.
Dr. Singh also emphasized the transformative role of Artificial Intelligence (AI) in healthcare, governance, and decision-making. AI-powered hybrid mobile clinics are already serving rural and remote areas, while the AI-driven grievance redressal system developed by the Department of Administrative Reforms and Public Grievances (DARPG) has achieved a 97–98% weekly disposal rate, improving citizen services.
Highlighting the convergence of innovation, collaboration, and compassion, Dr. Singh called for greater partnerships between government, academia, and private hospitals, asserting that these efforts will shape India’s journey toward a developed nation by 2047 and establish its leadership in global science and technology.
